State Street Corporation 13D and 13G filings for Catalyst Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-17 12:14 pm Sale | 2024-09-30 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | STATE STREET CORP STT | 5,685,330 4.800% | -1,102,002 (-16.24%) | Filing |
| 2024-01-25 10:09 am Sale | 2023-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | STATE STREET CORP STT | 6,787,332 6.370% | -1,085,982 (-13.79%) | Filing |
| 2023-02-08 10:44 am Purchase | 2022-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | STATE STREET CORP STT | 7,873,314 7.570% | 2,822,325 (+55.88%) | Filing |
| 2022-02-09 12:23 pm Sale | 2021-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | STATE STREET CORP STT | 5,050,989 4.900% | -1,062,941 (-17.39%) | Filing |
| 2021-02-05 12:32 pm Sale | 2020-12-31 | 13G | Catalyst Pharmaceuticals, Inc. CPRX | STATE STREET CORP STT | 6,113,930 5.900% | -1,304,365 (-17.58%) | Filing |